In a crossover trial of 10 infants with Prader-Willi syndrome and central sleep apnoea, supplemental oxygen lowered the central apnoea-hypopnoea index versus medical air (adjusted means 1.8 vs 9.4 events/hr; difference −7.7, p=0.048), with no meaningful hypercapnia.
RCTn = 10
Fishman et al. A comparison of therapeutic oxygen versus medical air for the treatment of central sleep apnea in infants with Prader-Willi syndrome; A proof-of-concept randomized crossover trial